In another CRISPR first, Penn researchers dose US cancer patients with gene-edited T cell therapy
CRISPR has been tested in US patients for the first time — but perhaps not in the manner you imagined.
The University of Pennsylvania has led …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
